Skip to content
Trial Eligibility
Menu

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

NCT07290140

This study is recruiting at 16 US sites in 11 states, according to its ClinicalTrials.gov record last updated .

Summary

This is a prospective, multicenter, randomized, controlled, double-blind clinical trial enrolling 300 adult subjects with chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP) indicated for endoscopic sinus surgery (ESS).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Airiver Medical, Inc.
Last updated on ClinicalTrials.gov
October 29, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 3

  • Excel ENT · Birmingham, AL
  • University of Alabama · Birmingham, AL
  • North Alabama ENT · Huntsville, AL

California · 1

  • SENTA Clinica · San Diego, CA

Colorado · 1

  • Colorado ENT & Allergy · Colorado Springs, CO

Iowa · 1

  • Physicians' Clinic of Iowa · Cedar Rapids, IA

Kansas · 1

  • KUMC · Kansas City, KS

Kentucky · 1

  • Advanced ENT · Louisville, KY

New York · 1

  • Montefiore Medical Center · The Bronx, NY

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

South Carolina · 2

  • Charleston ENT & Allergy · Charleston, SC
  • MUSC - Medical University of South Carolina · Charleston, SC

Texas · 3

  • Dallas ENT · Dallas, TX
  • Ear and Sinus Institute · Fort Worth, TX
  • ENT Associates of Texas · McKinney, TX

Virginia · 1

  • University of Virginia · Charlottesville, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.